Evidence map›Paper›PMID 38344717›Full record

ArticleKidney international reports2024

Clopidogrel for Proteinuria Reduction in Focal Segmental Glomerulosclerosis: Phase 2 Trial Design.

Lisa Daniel-Fischer, Marlies Antlanger, Daniel Cejka, Kathrin Eller, Philipp Gauckler, Balazs Odler, Michael Rudnicki, Marcus D Säemann, Alice Schmidt, Gere Sunder-Plassmann and 7 more

Open access · goldAbstract read
In one paragraph

Article in Kidney international reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 9 institutions in 2 countries.

Lisa Daniel-FischerDivision of Pediatric Nephrology and Gastroenterology, Department of Pediatrics and Adolescent Medicine, Comprehensive Center for Pediatrics, Medical University of Vienna, Vienna, Austria.
Marlies AntlangerDepartment of Internal Medicine 2, Faculty of Medicine, Kepler University Hospital, Johannes Kepler University, Linz, Austria.
Daniel CejkaDepartment of Internal Medicine 3 - Kidney and High-Pressure Diseases, Transplantation Medicine, Rheumatology, Ordensklinikum Linz-Elisabethinen, Linz, Austria.
Kathrin EllerDivision of Nephrology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
Philipp GaucklerDepartment of Internal Medicine IV (Nephrology and Hypertension), Medical University Innsbruck, Innsbruck, Austria.
Balazs OdlerDivision of Nephrology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
Michael RudnickiDepartment of Internal Medicine IV (Nephrology and Hypertension), Medical University Innsbruck, Innsbruck, Austria.
Marcus D Säemann6th Medical Department with Nephrology and Dialysis, Clinic Ottakring Vienna, Vienna, Austria.
Alice SchmidtDepartment of Medicine III, Division of Nephrology and Dialysis, Medical University of Vienna, Vienna, Austria.
Gere Sunder-PlassmannDepartment of Medicine III, Division of Nephrology and Dialysis, Medical University of Vienna, Vienna, Austria.
Martin WiesholzerClinical Department for Internal Medicine, University Hospital St Poelten, Karl Landsteiner University of Health Sciences, St Poelten, Austria.
Martin WindpesslDepartment of Internal Medicine IV, Section of Nephrology, Clinic Wels-Grieskirchen, Wels, Austria.
Emanuel ZittDepartment of Internal Medicine III (Nephrology, Dialysis and Hypertension), Academic Teaching Hospital Feldkirch, Feldkirch, Austria.
Franz KoenigCenter for Medical Data Science, Medical University of Vienna, Vienna, Austria.
Larry A GreenbaumDivision of Pediatric Nephrology, Department of Pediatrics, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, Georgia, USA.
Andreas KronbichlerDepartment of Internal Medicine IV (Nephrology and Hypertension), Medical University Innsbruck, Innsbruck, Austria.
Christoph AufrichtDivision of Pediatric Nephrology and Gastroenterology, Department of Pediatrics and Adolescent Medicine, Comprehensive Center for Pediatrics, Medical University of Vienna, Vienna, Austria.
Medical University of Vienna · ATInnsbruck Medical University · ATJohannes Kepler University of Linz · ATMedical University of Graz · ATEmory University · USKarl Landsteiner University of Health Sciences · ATKrankenhaus der Elisabethinen · ATLandeskrankenhaus Feldkirch · ATSigmund Freud University Vienna · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

clopidogreldrug repurposingFSGSproteinuria

Identifiers

PMID38344717
PMCPMC10850994
OpenAlexW4388304297

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.